Literature DB >> 21772144

Phantom limb pain and bodily awareness: current concepts and future directions.

Melita J Giummarra1, G Lorimer Moseley.   

Abstract

PURPOSE OF REVIEW: Phantom pain is a frequent consequence of amputation or deafferentation. There are many possible contributing mechanisms, including stump-related pathology, spinal and cortical changes. Phantom limb pain is notoriously difficult to treat. Continued consideration of the factors associated with phantom pain and its treatment is of utmost importance, not only to advance the scientific knowledge about the experience of the body and neuropathic pain, but also fundamentally to promote efficacious pain management. RECENT
FINDINGS: This review first discusses the mechanisms associated with phantom pain and summarizes the current treatments. The mechanisms underlying phantom pain primarily relate to peripheral/spinal dysfunction, and supraspinal and central plasticity in sensorimotor body representations. The most promising methods for managing phantom pain address the maladaptive changes at multiple levels of the neuraxis, for example, complementing pharmacological administration with physical, psychological or behavioural intervention. These supplementary techniques are even efficacious in isolation, perhaps by replacing the absent afferent signals from the amputated limb, thereby restoring disrupted bodily representations.
SUMMARY: Ultimately, for optimal patient outcomes, treatments should be both symptom and mechanism targeted.

Entities:  

Mesh:

Year:  2011        PMID: 21772144     DOI: 10.1097/ACO.0b013e32834a105f

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  14 in total

1.  [Mirror therapy for the treatment of phantom limb pain after bilateral thigh amputation. A case report].

Authors:  M Wosnitzka; M Papenhoff; A Reinersmann; C Maier
Journal:  Schmerz       Date:  2014-12       Impact factor: 1.107

Review 2.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

Review 3.  Pharmacologic interventions for treating phantom limb pain.

Authors:  Maria Jenelyn M Alviar; Tom Hale; Monalisa Dungca
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

4.  Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.

Authors:  John H Alexander; Sumanas W Jordan; Julie M West; Amy Compston; Jennifer Fugitt; J Byers Bowen; Gregory A Dumanian; Raphael Pollock; Joel L Mayerson; Thomas J Scharschmidt; Ian L Valerio
Journal:  J Surg Oncol       Date:  2019-06-13       Impact factor: 3.454

5.  Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma.

Authors:  Zhen-Zhong Xu; Xing-Jun Liu; Temugin Berta; Chul-Kyu Park; Ning Lü; Charles N Serhan; Ru-Rong Ji
Journal:  Ann Neurol       Date:  2013-09-04       Impact factor: 10.422

6.  Tactile, thermal, and electrical thresholds in patients with and without phantom limb pain after traumatic lower limb amputation.

Authors:  Shengai Li; Danielle H Melton; Sheng Li
Journal:  J Pain Res       Date:  2015-04-20       Impact factor: 3.133

7.  Loss of long-term depression in the insular cortex after tail amputation in adult mice.

Authors:  Ming-Gang Liu; Min Zhuo
Journal:  Mol Pain       Date:  2014-01-08       Impact factor: 3.395

Review 8.  Assistive technologies for pain management in people with amputation: a literature review.

Authors:  Kamiar Ghoseiri; Mostafa Allami; Mohammad Reza Soroush; Mohammad Yusuf Rastkhadiv
Journal:  Mil Med Res       Date:  2018-01-23

9.  Feeling the pain of others is associated with self-other confusion and prior pain experience.

Authors:  Stuart W G Derbyshire; Jody Osborn; Steven Brown
Journal:  Front Hum Neurosci       Date:  2013-08-14       Impact factor: 3.169

10.  Evidence for distorted mental representation of the hand in osteoarthritis.

Authors:  Helen R Gilpin; G Lorimer Moseley; Tasha R Stanton; Roger Newport
Journal:  Rheumatology (Oxford)       Date:  2014-09-22       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.